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sing the Cre/loxP system we conditionally inactivated
 
 
 
-catenin
 
 in endothelial cells. We found that early
phases of vasculogenesis and angiogenesis were not
affected in mutant embryos; however, vascular patterning
in the head, vitelline, umbilical vessels, and the placenta
was altered. In addition, in many regions, the vascular lumen
was irregular with the formation of lacunae at bifurcations,
vessels were frequently hemorrhagic, and ﬂuid extravasation
in the pericardial cavity was observed. Cultured 
 
 
 
-catenin
 
 
 
/
 
 
 
 endothelial cells showed a different organization of
U
 
intercellular junctions with a decrease in 
 
 
 
-catenin in favor
of desmoplakin and marked changes in actin cytoskeleton.
These changes paralleled a decrease in cell–cell adhesion
strength and an increase in paracellular permeability. We
conclude that in vivo, the absence of 
 
 
 
-catenin signiﬁcantly
reduces the capacity of endothelial cells to maintain inter-
cellular contacts. This may become more marked when the
vessels are exposed to high or turbulent ﬂow, such as at
bifurcations or in the beating heart, leading to ﬂuid leakage
or hemorrhages.
 
Introduction
 
Endothelial cells are linked one to another through adhesive
junctional structures that include tight and adherens junctions
(Takeichi, 1990; Dejana et al., 1995; Gumbiner, 1996,
2000; Tsukita et al., 2001). Adherens junctions are formed
by an endothelial-specific member of the cadherin family
called VE-cadherin, which forms zipper-like structures along
the cell periphery and promotes cell–cell adhesion (Dejana
et al., 1999). Furthermore, in lymphatics and some venous
endothelium, VE-cadherin takes part in the organization of
 
complexus adhaerentes
 
 (Schmelz et al., 1994). In these
junctional structures, VE-cadherin is linked to plakoglobin,
which through binding to desmoplakin, can mediate the
anchorage to vimentin (Franke et al., 1988; Dejana et al.,
1995; Valiron et al., 1996; Kowalczyk et al., 1998).
The null mutation of 
 
VE-cadherin
 
 prevented vascular
remodeling and induced degeneration and regression of
vascular structures resulting in early fetal death (Carmeliet et
al., 1999). These defects may be due to the lack of both
adhesive and signaling properties of the protein. VE-cadherin
may signal through 
 
 
 
-catenin, which binds cadherin cyto-
plasmic tail and 
 
 
 
-catenin, which in turn links the complex
to actin cytoskeleton (Aberle et al., 1996; Zhurinsky et al.,
2000). However, when 
 
 
 
-catenin is released and stabilized
in the cytosol, it translocates to the nucleus, associates Tcf
transcription factors, and modulates gene transcription
(Gumbiner, 1995; Behrens et al., 1996; Miller and Moon,
1996; Zhurinsky et al., 2000; Hurlstone and Clevers, 2002).
Therefore, cadherins (and VE-cadherin in particular) may
signal in an indirect way by maintaining 
 
 
 
-catenin at the
membrane and preventing its nuclear translocation.
Furthermore, a large family of growth and differentiation
factors called Wnts acts through 
 
 
 
-catenin stabilization and
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Abbreviation used in this paper: E, embryonic day.T
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transcriptional activity (Peifer and Polakis, 2000). Endo-
thelial cells express some Wnt receptors, denominated friz-
zled (Li et al., 1999), and bind and respond to Wnt-1
(Wright et al., 1999).
 
 
 
-Catenin is rather ubiquitous, and inactivation of its
gene results in the death of the embryo at gastrulation due to
defects in anterior–posterior axis formation and mesoderm
organization (Haegel et al., 1995; Huelsken et al., 2000). To
study the role of 
 
 
 
-catenin in the development of the vascu-
lar system, we undertook a conditional gene inactivation
strategy using the Cre/loxP system and 
 
Tie2-Cre
 
 transgenic
animals. Tie2 is an endothelial specific receptor, and the
promoter has cell specific expression (Schlaeger et al., 1997;
Kisanuki et al., 2001).
We found that mutant embryos die in utero within em-
bryonic day 11.5–13.5 (E11.5–13.5) due to alterations of
vascular morphogenesis. Vessels have enlarged or irregular
lumen, an altered network organization, and are frequently
hemorrhagic. At EM, endothelial cells present increased fen-
estration, and intercellular junctions appear less convoluted.
Endothelial cells cultured from 
 
 
 
-catenin
 
–null animals have
a different organization of adherens junctions: 
 
 
 
-catenin is
substantially reduced, whereas junctional desmoplakin is
markedly increased. It is likely that vascular fragility and the
presence of lacunae at bifurcations, observed at times of sus-
tained shear stress, are due to inadequate junctional organi-
zation and intercellular adhesion.
 
Results
 
 
 
-Catenin
 
 gene inactivation in endothelial cells 
is embryonically lethal
 
To specifically inactivate the 
 
 
 
-catenin
 
 gene in endothelial
cells, mice containing a floxed 
 
 
 
-catenin
 
 allele were inter-
crossed with transgenic mice expressing 
 
Cre
 
 under the con-
trol of 
 
Tie2
 
 endothelial-specific promoter (Schlaeger et al.,
1997; Brault et al., 2001; Kisanuki et al., 2001). The 
 
 
 
-cate-
nin
 
 flox mice have been used successfully to inactivate 
 
 
 
-cate-
nin
 
 in vivo (Brault et al., 2001; Hari et al., 2002; Lickert et
al., 2002). The four genotypes obtained from the crossing
are shown in Fig. 1 A (see Materials and methods for the
mating strategy). The ability of Tie2-Cre to recombine the
flox allele specifically in the endothelium was tested by geno-
mic PCR from embryonic yolk sacs. As reported in Fig. 1 A,
the flox del allele was detected only in E10.5 animals positive
for 
 
Tie2-Cre
 
 (Fig. 1 A, compare lane 3 and lane 4), suggest-
ing that 
 
Cre
 
 expression in the endothelial cells of the yolk sac
was capable of recombining the loxP sites within 
 
 
 
-catenin
Figure 1. Cre recombinase efficiently recombines the  -catenin flox allele in vivo. (A) Genomic PCR on E10.5 embryos from Tie2-Cre x 
 -catenin flox/flox crossings for the  -catenin gene and for Tie2-Cre gene. The four lanes represent the four different genotypes obtained: 
 -catenin flox del/flox, Cre
  ( / , lane 1),  -catenin flox del/flox, Cre
  ( / , lane 2),  -catenin flox/wt, Cre
  ( / , lane 3), and  -catenin 
flox/wt, Cre
  ( / , lane 4). In this last lane, note the presence of the recombined  -catenin flox del band when the flox allele is in the presence 
of Tie2-Cre recombinase. (B) Western blot of  -catenin protein in endothelial cell lines established from wt (control) and  -catenin flox/flox 
del, Tie2-Cre
  embryos ( / ). (C-J) Immunofluorescence for anti-PECAM and anti- -catenin antibodies on serial cryosections from wild-type 
( / , control) and  -catenin flox/flox del, Tie2-Cre
  ( / , mutant) E10.5 embryos. Heart sections show positive staining of the endocardium (e) 
with PECAM antibodies in both control (C) and  -catenin  /  (E) animals.  -Catenin staining is undetectable in mutant embryos (F). 
 -Catenin is also absent in the dorsal aorta (G and H, Ao) and in the yolk sac vessels (I and J, arrow) of the mutant embryos. Bar in H refers to 
C–H, and bar in J refers to I and J.T
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gene. The presence of the unrecombined flox allele in the
same lane is attributable to the nonendothelial cells abound-
ing in the yolk sac used for the genomic PCR. The flox del
allele was detected as early as E8.5 (unpublished data). Ex-
amination of the offspring indicated that heterozygous (Fig.
1 A, lane 1 and lane 4) were viable and fertile and appeared
to be normal. In contrast, no mouse with endothelial 
 
 
 
-cate-
nin
 
 flox del/flox del (Fig. 1 A, lane 2) was born (Table I). An-
alyzing the embryos at different times after conception, we
found that up to 9.5 d, 
 
 
 
-catenin
 
 mutants were morphologi-
cally indistinguishable from control embryos (either wild
types or littermates that had not inherited the complete set of
alleles). However, 
 
 
 
50 and 100% of embryos died within
E11.5 and E13.5, respectively (Table I).
 
Cre
 
 expression in 
 
Tie2-Cre
 
 animals crossed with ROSA26R
was previously found in endothelial and endocardial cells at
E8.5 and at E7.5 in a subset of extra embryonic mesodermal
components of the yolk sac, considered as endothelial pre-
cursors (unpublished data; Kisanuki et al., 2001). No signif-
icant 
 
Cre
 
 expression was found in other tissues (Kisanuki et
al., 2001).
Tissues and cell types, but not endothelial cells, were posi-
tive for 
 
 
 
-catenin staining by immunohistochemistry, indi-
cating that inhibition of 
 
 
 
-catenin
 
 expression was specific for
endothelial cells (a typical staining is reported in Fig. 1, C–J).
To unequivocally prove that the 
 
 
 
-catenin
 
 gene was fully
inactivated in endothelial cells, we isolated and cultured
endothelial cell lines from 
 
 
 
-catenin
 
 
 
 
 
/
 
 
 
 (control) and 
 
 / 
animals. Three different cell lines have been examined,
derived from animals at 9.5 d of development, and none of
them expressed detectable amounts of  -catenin by West-
ern blot (Fig. 1 B) or PCR analysis (unpublished data). In
some cases, contaminating fibroblasts were observed at
early stages of culture of the cells, which presented positive
staining for  -catenin at immunofluorescence (unpub-
Table I. Genotype of progeny from  -catenin flox/flox x 
Tie2-Cre intercrosses
Endothelial  -catenin genotype
a Number of 
viable  / 
 /   /   / 
E9.5 12 (21) 30 (55) 13 (23) 13 (100)
E10.5 30 (19) 87 (56) 39 (25) 37 (95)
E11.5 41 (27) 71 (46) 42 (27) 21 (50)
E12.5 4 (31) 4 (31) 5 (38) 1 (20)
E13.5 1 (5) 14 (70) 5 (25) 0
P20 25 (36) 44 (64) 0 0
E, embryonic day; P, postnatal day.
aNumbers are given with percentage in parentheses.
Figure 2. Phenotypic defects in endothelial  -catenin–null 
embryos. (A and B) E9.5 embryos after whole-mount immunohis-
tochemistry with anti-PECAM antibodies. No major differences can 
be observed in the vascular phenotype of control (A) and mutant (B) 
embryos at this stage. (C–J) E10.5 embryos. Although major vitelline 
vessels are visible in control embryos after dissection (C, arrows), the 
mutant yolk sac appeares paler (D). In E–H, K, and L, whole-mount 
staining for PECAM was performed. In E (control) and F (mutant), 
note the difference in diameter of vitelline (vv) and major vessels 
(arrowheads) in the yolk sac. In both control (G) and mutant 
embryos (H), PECAM and nuclear fast red staining of yolk sac sections 
shows essentially indistinguishable vessels with the presence of 
endothelial (e), mesothelial (m), blood (b), and endodermal cells (n). 
(I–L) Umbilical vessels (uv) in 10.5 (I and J) and 11.5 embryos (K and 
L). In the mutants, umbilical vessels are smaller in diameter, ramified, 
or anastomosed (J and L) as compared with the control (I and K). 
h, heart; em, embryo; pl, placenta. Bars, 100  m.T
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lished data). However, only cells negative for VE-cadherin
were positive for  -catenin, further indicating cell-specific
inactivation of  -catenin gene.
Vascular defects in endothelial  -catenin  /  mutants
At E9.5, endothelial  -catenin mutant mice were morpho-
logically indistinguishable from control littermates and
showed a similar vascular pattern in the embryo proper as
well as in the yolk sac (Fig. 2, A and B; unpublished data).
However, at E10.5, the  -catenin mutant mice had pale and
less perfused yolk sacs (Fig. 2, C and D). In the yolk sac of
mutant embryos, the primary vascular plexus was present
and correctly organized, whereas the vitelline vessels pre-
sented a smaller diameter (Fig. 2, E and F). The average di-
ameter of the vitelline vessels connecting the embryo to the
yolk sac (Fig. 2, E and F, arrows) was 60   30  m in the
 -catenin mutant mice and 145   10  m in the control.
The maximum diameter of the vitelline vessels in the yolk
sac (Fig. 2, E and F, arrowheads) was 82   18  m in the
mutant and 170   20  m in the control (numbers obtained
out of five embryos). The number of branches was not sig-
nificantly different for the same vessel length comparing
mutant and control embryos (6.3   1.1 primary branches in
the mutant and 5.3   1.5 in the control for 2 mm length of
the major vitelline vessel, measured out of three embryos).
Histological sections of the yolk sac showed the presence of
endodermal (n), endothelial (e), mesothelial (m), and nucle-
ated blood cells (b) in both control (Fig. 2 G) and mutant
(Fig. 2 H) mice. Umbilical vessels were often increased in
number, presented a markedly smaller diameter, and were
abnormally branched or anastomosed, as compared with
controls (Fig. 2, I–L).
In the embryo proper, the vascular pattern in the head
was defective (Fig. 3, A–D). Whole-mount staining with
anti-PECAM antibodies showed an altered development of
blood vessels in the primitive neural plexus. Namely, blind
Figure 3. Vascular defects in the placenta 
and head of endothelial  -catenin–null 
embryos. Whole-mount immunohisto-
chemistry for anti-PECAM antibody in E10.5 
embryos (A and B). In the head, mutant 
embryos (B and D) compared with controls 
(A and C) show a less organized vascular 
network with vessels of irregular diameter 
and shape. In mutants, blind ending vessels 
(B, arrowhead) and lacunae-like bifurcations 
(D, arrowhead) can be often observed. PE-
CAM and nuclear fast red staining in two 
serial transverse sections, separated by 
60  m, of E10.5 mutant head (E and F). The 
arrows point to the diameter of the internal 
carotid artery, which is significantly different 
in the two sections. Placenta histology of 
control (G and I) and mutant E10.5 embryos 
(H and J) shows that, although the maternal 
decidua (md), the chorionic plate (cp), and 
the trophoblast giant cells (tgc) are compa-
rable, the labyrinthine layer (lbr) is reduced 
in mutants. I and J represent higher magnifi-
cations of the zones indicated by the asterisks 
in G and H, respectively. Embryonic blood 
vessels (arrows), are substantially more 
abundant in the labyrinthine zone of the 
control (I), than in the mutant (J).T
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ending vessels and the formation of lacunae-like bifurca-
tions were observed in the mutants (Fig. 3, B and D, arrow-
heads). Furthermore, cephalic vessels in the mutants showed
an inconstant diameter and often formed acute turns and
branching as compared with the control (Fig. 3, C and D,
arrowhead). Transverse histological sections of the head
confirmed the irregularity of vessel diameter, as indicated,
by the different size of the internal carotid artery, shown in
two sequential sections of the mutant embryos (Fig. 3, E
and F, arrows).
Placenta tissues presented differences in mutant embryos.
Although the chorionic plate and trophoblast giant cells ap-
peared to be normal, the labyrinthine layer was reduced in
thickness and less vascularized as compared with control lit-
termates. A reduced number of fetal blood vessels penetrated
in the labyrinthine area, and they mainly remained concen-
trated in the chorionic plate (Fig. 3, G–J, arrows).
About 50% of the embryos presented hemorrhages in dif-
ferent vascular areas such as the head and the dorsal vessels
(Fig. 4, B and C, arrowheads). The heart of the mutant em-
bryos was significantly smaller as compared with the wild
type, and frequently showed extensive liquid accumulation
in the pericardial cavity (Fig. 4, D and E, arrows).
 -catenin  /  endocardial and vascular endothelial 
cells are morphologically altered in vivo
As shown in Fig. 5, in mutant embryos endocardial and vas-
cular endothelial cells were more elongated than control ves-
sels, resulting in a continuously thinner endothelial layer.
The absolute minimum thickness of the endothelium in-
stead was not altered (Fig. 5, A and B). Junctional overlap-
ping typical of endothelial cells was impaired and consis-
tently reduced in essentially all the specimens considered
(Fig. 5, C and D).
In addition to the changes in cell and junction morphol-
ogy, mutant endothelial cells presented a higher degree of
fenestration. These structures are discontinuities in the en-
dothelial cell membranes, allowing the passage of small
mol wt constituents and which likely derive from a fusion
of the apical and basal membrane (Feng et al., 1999). Typ-
ical examples are reported in Fig. 5 (E and F), in which
yolk sac endothelial cells are analyzed. In control embryos,
the yolk sac endothelium was only poorly fenestrated along
the vessel wall. In contrast, in mutant endothelium a six-
fold increase in the number of fenestrae could be observed
(Fig. 5 G).
 -catenin  /  endothelial cells present altered 
intercellular junctional organization both in vitro 
and in vivo
To study whether the morphological and functional defects
observed in  -catenin  /  endothelial cells in vivo were in-
dependent from their tissue context, we isolated and cul-
tured endothelial cells from mutant and wild-type embryos.
 -Catenin  /  endothelial cells presented all endothelial
markers analyzed (Fig. 6–8; unpublished data), but cell mor-
phology was significantly different.  -Catenin   /  cells
were more elongated as compared with control cells (Fig. 6,
C and D), and presented thinner and longer bundles of actin
filaments, with sensibly less organized anchorage sites at the
periphery of the cell (Fig. 6, E and F).
To understand whether changes observed were due to
modifications acquired during embryonic development, we
cultured endothelial cells from  -catenin flox/flox del Cre
 
( / ) animals, which did not present any apparent devel-
opmental alterations. These cells were infected with an ad-
eno vector expressing Cre recombinase (Anton and Graham,
1995; Wang et al., 1995) in order to inactivate  -catenin
gene in vitro. Western blot analysis confirmed the absence
of   -catenin in these cells (Fig. S3, available at http://
www.jcb.org/cgi/content/full/jcb.200212157/DC1), and
they underwent similar changes in morphology and cyto-
Figure 4. Hemorrhages and fluid extra-
vasation in  -catenin mutant embryos. 
E10.5 control (A and D) and mutant 
embryos (B, C, and E). Arrowheads in B 
and C indicate regions of extended hem-
orrhages. In the mutants, we observed 
fluid accumulation in the pericardial 
cavity (arrow in E in comparison to 
controls in D) suggesting increase of per-
meability of cardiac microvasculature.T
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skeletal organization as  -catenin  /  cells derived from
embryos (see Fig. 6, A–D, and Fig. S1).
The   /  cells were cultured and systematically com-
pared with  -catenin  /  and  /  cells. To exclude the
toxicity of Cre recombinase, we also cultured endothelial
cells derived from flox/wt Cre
  animals ( / ). In all the as-
says performed, these cell types were indistinguishable from
 -catenin  /  cells.
The expression and distribution of junctional markers
was studied by immunofluorescence microscopy. We ob-
served that essentially all the junctional proteins considered
(including PECAM, JAM, VE-cadherin, ZO-1, p120, and
occludin) were correctly expressed and distributed at in-
tercellular junctions (see Figs. 6–8; unpublished data).
The only exceptions were plakoglobin, which presented a
slightly brighter staining at intercellular contacts (Fig. 7, A
and B), and  -catenin, which was strongly reduced at cell–
cell contacts (Fig. 7, C and D). These observations were
further confirmed by biochemical analyses. Immunoprecip-
itation of VE-cadherin followed by Western blot with
specific antibodies revealed changes in cadherin–catenin
complex composition.  -catenin was strongly reduced
(4–5-fold) in the complex and in total amount, whereas
plakoglobin was slightly increased (1–1.5-fold; Fig. 8 A).
The total level of p120 and VE-cadherin and their level as-
sociated to the complex were comparable (Fig. 8 A; unpub-
lished data). Because  -catenin was reduced, plakoglobin
could have another partner. Desmoplakin is a preferential
binding protein for plakoglobin, but is weakly expressed in
vascular endothelium (Franke et al., 1988; Schmelz et al.,
1994). We found that desmoplakin was 2–3-fold increased
in extracts of  -catenin  /  cells as compared with con-
trols (Fig. 8 B). In addition, desmoplakin was found at in-
tercellular contacts only in  -catenin  /  cells, but not in
control cells (Fig. 7, E and F). The same characterization of
adherens junctions composition was performed in  -cate-
nin flox endothelial cells treated either with adeno-Cre or
the empty vector, and we found essentially the same results
(Figs. S1–S3, available at http://www.jcb.org/cgi/content/
full/jcb.200212157/DC1).
The organization of endothelial cell junctions was also
studied in vivo by immunostaining of vascular sections of
E10.5 embryos. Consistently with the data obtained on cul-
tured cells, we found that  -catenin was barely visible at in-
terendothelial contacts of mutant embryos as compared with
controls (Fig. 9, A–D). Desmoplakin was detectable only in
the endothelium of mutant mice, but not in controls (Fig. 9,
E to H, arrows). VE-cadherin and plakoglobin were cor-
rectly expressed in mutant and control mice (Fig. S4, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200212157/
DC1). Therefore, endothelial immunostaining in vivo sup-
ports the observations made on cultured cells.
Figure 5. Thinner endocardium and increased number of fenes-
trations in  -catenin–null embryos. In electron micrographs, the 
endocardial lining of the heart appear continuously thinner in the 
null embryos compared with control littermates (compare A with B), 
whereas the myocardium is equally organized (not depicted). 
Ultrathin sections of yolk sac vessels of control and mutant embryos 
show similar features as the heart endocardium, with thinner 
endothelial walls and less organized junctions in  -catenin–deficient 
embryos. In the latter, the inter-endothelial junctions show a reduced 
junctional overlapping (see arrows), as compared with controls 
(C and D; asterisks point to fenestrations). Furthermore, a higher 
incidence of fenestrations (asterisks) in the yolk sac vasculature of 
null embryos can be observed (compare D, E, and F), which are 
quantified as number of fenestrae per length unit of endothelial wall 
(G; 10 pictures counted for each genotype).T
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Cell–cell adhesion strength is reduced in absence 
of  -catenin
When intercellular junctions are affected, cells tend to de-
tach from the monolayer and migrate as single cells (Corada
et al., 2002). As reported in Fig. 10 (A–C), single migrating
cells were very few in control monolayers, whereas cells lack-
ing  -catenin detached from the monolayer and migrated
into the wound much more efficiently. Differences in cell
migration velocity or cell proliferation at the cell front
Figure 6. Morphological differences and junctional organization in 
control and  -catenin  /  endothelial cells in culture. A represents 
 -catenin flox/flox del (control) endothelial cells, whereas B repre-
sents the same cells after infection with an adeno vector express-
ing Cre recombinase ( -catenin flox del/flox del, or  / ). In C, E, 
and G, endothelial cells cultured from control embryos are shown, 
whereas D, F, and H show endothelial cells from  -catenin  /  
embryos. Although control endothelial cells exhibit classical cobble-
stone morphology (A and C),  -catenin  /  cells are more elon-
gated and have a fibroblastoid/mesenchymal morphology (B and D). 
Phalloidin staining shows more elongated and thinner bundles of ac-
tin filaments in  -catenin  /  cells (F), as compared with controls 
(E).  -Catenin staining is undetectable at intercellular contacts of 
 /  cells (compare G and H), whereas ZO-1 (I and J) and VE-cad-
herin (K and L) are correctly organized at intercellular junctions.
Figure 7. Immunostaining of junctional proteins in  -catenin  /  
endothelial cells. Although plakoglobin is correctly organized at 
cell–cell contacts in  -catenin  /  embryos (compare A and B), 
 -catenin antibodies give a very faint and discontinuous staining at 
cell–cell contacts in  -catenin  / , as compared with control cells 
(compare C and D). Note the presence of desmoplakin at intracellular 
junctions only in  -catenin  /  cells (F, arrows), whereas in control 
cells, the same antibody gives only a faint and diffuse staining (E).
Figure 8. Biochemical characterization of the junctional complex. 
(A) Association of VE-cadherin with  ,  -catenins, and plakoglobin. 
Endothelial cell extracts from control and  -catenin  /  cells were 
immunoprecipitated with antibodies to VE-cadherin. The immuno-
precipitates (IP) and an equal amount of total protein extracts (Total) 
from the two cell types were immunoblotted (IB) with the antibodies 
indicated on the left. Note the decrease in the level of both total and 
VE-cadherin-bound  -catenin. (B) Increase in desmoplakins level in 
 -catenin  /  and in control cell lysates. Arrowheads indicate the 
bands corresponding to desmoplakin I (250 kD) and II (220 kD).T
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among  -catenin  /  and  /  cells were excluded by the
phagokinetic track assay and BrdU incorporation respec-
tively (see supplemental Materials and methods section,
Fig. S5; available at http://www.jcb.org/cgi/content/full/
jcb.200212157/DC1).
As a second assay, we tested paracellular permeability of
endothelial cell monolayers grown on Transwell filters (Co-
rada et al., 2002). As reported in Fig. 10 D,  -catenin  / 
cells were more permeable to high mol wt dextran as com-
pared with control cells. Cell density was not significantly
different between the two cell lines as measured by crystal vi-
olet staining of the cells grown on the filters at d 4 (in a typ-
ical experiment, OD 540 nm of  -catenin  /  cells was
1.216   0.13 and  -catenin  /    1.495   0.06; values
are means of four filters   SD).
Finally, we tested the mutant cell lines for their capacity to
aggregate and form cords in Matrigel™ matrix. As shown in
Fig. 10 (E–H), cells lacking  -catenin were unable to orga-
nize in aggregates or cords of large diameter, but tended to
form only thin filaments connecting small and disorganized
cell clumps.
Figure 9. Junctional organization in control and mutant 
embryos. Cryosections from E10.5 embryos were analyzed for 
the codistribution of PECAM (A and B) and  -catenin (C and D). 
PECAM is equally expressed in control (A) and mutant embryos 
(B), and in some regions it is possible to evidentiate its localization 
at cell–cell contacts (arrows). In contrast, in mutant embryos 
 -catenin shows a weaker endothelial staining and colocalization 
with PECAM at intercellular junctions is rare (compare C and D, 
arrows). Desmoplakin is detectable in endothelial cells in  -catenin–
null embryos and colocalizes with PECAM at cell–cell contacts 
(F and H). In control embryos desmoplakin staining was negative 
in endothelial cells (E and G). e, endocardium. Bar in H refers 
to A–H.
Figure 10. Cell–cell adhesion strength in control and mutant 
endothelial cells. (A–C) Analysis of endothelial cell migration into 
a wound. Crystal violet staining of control (A) and  -catenin  /  
(B) endothelial cells 8 h after mechanical wounding of the mono-
layer. C reports the number of migrating single cells into the wound at 
8 h. (D) Permeability across endothelial cell monolayers.  -Catenin 
 /  confluent endothelial cells show a higher passage of FITC-
dextran as compared with the control cells. In C and D, columns 
represent means   SEM of quadruplicates of a typical experiments 
out of three performed. (E–H)  -catenin–null endothelial cells ( / ) 
form only small, disorganized aggregates interconnected with thin, 
single-cell elongations on Matrigel™ matrix (G and H), whereas 
control endothelial cells are able to organize into aggregates 
and bundles and show a typical cordlike structure on Matrigel™ 
matrix (E and F).T
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Discussion
In this paper, we report that endothelial cells do not need
 -catenin for early phases of vasculogenesis and angiogene-
sis, but require this molecule for correct vascular patterning
and maintenance of vascular integrity at later stages of devel-
opment. The defects in  -catenin–null animals were local-
ized in specific regions such as the head vascular network,
large vitelline and umbilical vessels, and the placenta.
Placental insufficiency and hypoxia might be the cause of
death and of some defects of the mutant embryos (such as
the smaller diameter of vessels in the yolk sac). However,
many of the phenotypic alterations observed (such as the
abnormal branching of umbilical vessels, lacunae-like bifur-
cations, blind ending or inconstant diameter of vessels, lo-
calized hemorrhages in different regions of the microvascu-
lature, or changes in junction organization) appear specific
because they are not shared by embryos with comparable
placental insufficiency (Kozak et al., 1997; for review see
Roberts et al., 2001; Kuang et al., 2002; Yang et al., 2003).
A serious concern for the late and localized vascular de-
fects in  -catenin  /  embryos may be a partial, late, non-
uniform, or ectopic expression of Tie2-Cre transgene. How-
ever, from different evidences this possibility seems unlikely.
First, the Tie2 transgene is expressed in hemangioblasts at
early (E7.5) stages of development (Kisanuki et al., 2001),
and is able to induce recombination of the  -catenin gene in
vivo at least at E8.5 (this paper). Therefore, endothelial cells
in the progeny should present the recombined gene as
proven by histological staining of the endothelium in differ-
ent vessels in vivo and by isolating and culturing endothelial
cell lines from mutant embryos. Staining in vivo and cell
cultures were obtained from embryos at E9.5 when no ap-
parent vascular defect was yet detectable. In both cases,
 -catenin was undetectable arguing against a partial effect of
the recombinase. Furthermore, ectopic expression of the
transgene also looks unlikely, as shown by positive staining
of the surrounding nonendothelial tissues and by experi-
ments performed using the same animal strains crossed with
“indicator” mice expressing a floxed stop codon for Lac Z
expression (Kisanuki et al., 2001).
A typical defect of  -catenin–null animal vessels was the
abnormal, frequently inconsistent lumen accompanied by
the diffuse occurrence of hemorrhages. Changes in endothe-
lial cell morphology and function in the mutants may ex-
plain, at least in part, the phenotype. At EM, endothelial
cells of  -catenin–null animals were more flatten and elon-
gated. Inter-endothelial junctions looked less elaborate com-
pared with control animals, and the incidence and number
of fenestrae were increased. All these changes would argue in
favor of more fragile and permeable vessels, which would ex-
plain the presence of vascular leakage and hemorrhages.
This possibility is further supported by analyses on cul-
tured   -catenin–null endothelial cells. These cells present
differences in morphology and cytoskeletal organization
and, most importantly, in the molecular organization of ad-
herens junctions, where  -catenin was markedly decreased.
In other experimental systems, similar changes parallels
marked junction weakening (Kuroda et al., 1998; Va-
sioukhin et al., 2000).
In contrast to epithelial cells, endothelial cells do not have
desmosomes, neither do they express desmogleins or desmo-
collins (Franke et al., 1988). However, they have complexus
adhaerentes (Schmelz et al., 1994) formed by VE-cadherin
linked to plakoglobin or p0071 (Calkins et al., 2002), which
through the binding to desmoplakin, mediate the anchorage
to vimentin (Valiron et al., 1996; Kowalczyk et al., 1998;
Gallicano et al., 2001). Although desmoplakin and vimentin
are present in other types of endothelium (Valiron et al.,
1996; Kowalczyk et al., 1998), complexus adhaerentes are pref-
erentially observed in lymphatics, where junctions are rela-
tively weak, allowing a dynamic passage of cells and solutes
(Schmelz et al., 1994; Stacker et al., 2002). We speculate that
in the absence of  -catenin, plakoglobin may bind to  -cate-
nin only to a limited extent while increasing its interaction
with desmoplakin (see the scheme in Fig. 11). According to
this model, we found that both the level of desmoplakin and
its distribution at intercellular junctions were significantly in-
creased in  -catenin  /  cells. These molecular changes lead
to an overall decrease of the number of strong, actin-based
adherens junctions to weak, more dynamic vimentin based
complexus adhaerentes. Consistently, it was recently reported
that  -catenin is reduced in lymphatic as compared with vas-
cular endothelium (Petrova et al., 2002).
In vivo, EM showed morphological changes of endothelial
cells in different parts of the vasculature and also in regions
where vessels were apparently not severely affected, such as
in the microvasculature of the yolk sac or at early develop-
mental stages. It is possible that when vessels are exposed to
low hemodynamic stress, such as at early stages of develop-
ment or in regions of low shear, the defects due to the lack of
 -catenin remain silent. In contrast, when vessels are ex-
posed to high shear, such as in small arteries, at bifurcations
or in the heart, the endothelial cells are stretched and inter-
endothelial junctions may break causing vascular leakage.
This would explain the late and localized occurrence of vas-
cular dilations and hemorrhages.
Figure 11. Proposed model for the molecular reorganization of 
endothelial intercellular junctions in the absence of  -catenin. 
(A) In the presence of  -catenin ( ),  -catenin ( ) is normally 
expressed at cell–cell junctions and connects VE-cadherin/ -catenin 
or VE-cadherin/plakoglobin (PG) complex to actin cytoskeleton. 
(B) In the absence of  -catenin, the decrease in  -catenin, accom-
panied by increase in desmoplakin (DP), may lead to a shift from 
 -catenin and actin based junctions to desmoplakin and vimentin-
based complexus adhaerentes.T
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In other cells, such as in the epithelium, inactivation of
 -catenin did not modify intercellular cell–cell adhesion
strength (Huelsken et al., 2000; Posthaus et al., 2002).
However, this may be due to the presence of other strong
junctional structures such as desmosomes or more elabo-
rated tight junctions (Milton and Knutson, 1990).
Besides its role as cadherin partner,  -catenin is an impor-
tant signaling and transcriptional factor. The absence of
 -catenin would lead to a block of Wnt signaling in endo-
thelial cells. The role of Wnt in vascular development is still
largely obscure. Inactivation of Fzd 5 gene, a receptor of
Wnt 5a, Wnt 10b and Wnt 2, is embryonically lethal due to
defects in vascular organization in the yolk sac and placenta
(Ishikawa et al., 2001). These defects, such as reduction of
large vessel lumen in the yolk sac, were, for many aspects,
similar to those observed in  -catenin  /  animals in the
same organs, suggesting that they are due to a lack of  -cate-
nin transcriptional activity. However, in contrast to this last
report, we were unable to detect significant endothelial cell
detachment or apoptosis in the vessels of the yolk sac. A pos-
sible explanation is that Fzd 5 is expressed also in cells sur-
rounding the endothelium and the apoptotic effect may be
the result of an altered interaction of the endothelium with
the mesenchyma.
To test the possibility that some of the observed changes
in junctional protein expression, such as  -catenin, may
be due to  -catenin transcriptional activity, we infected
 -catenin  /  endothelial cells with two different con-
structs with constitutive Lef/ -catenin transcriptional ac-
tivity (LEF N- CTA and LEF N-VP16, a gift from Kris
Vleminckx; Vleminckx et al., 1999). We found that al-
though both constructs were able to increase the expression
of known target genes for  -catenin signaling, such as cy-
clin D1, none of them changed  -catenin expression (Fig.
S6, available at http://www.jcb.org/cgi/content/full/
jcb.200212157/DC1) or cell morphology. In addition, ac-
cording to the only available paper on the effect of Wnt-1
overexpression and  -catenin transcriptional activity in
cultured brain microvascular endothelial cells (Wright et
al., 1999), we cocultured endothelial cells with 293 cells
transfected with a vector expressing Wnt-1. Also in this
case, using different culture conditions, we could not de-
tect changes in adherens junction composition or cell mor-
phology (unpublished data). Overall, these data suggest
that the classic Wnt signaling pathway doesn’t play a major
role in the reported junctional changes.
In a transgenic mouse model with a reporter gene under
the control of  -catenin/TCF-responsive elements (Maretto
et al., 2003), reporter activity in blood vessels was found
from E10.5, but only at distinct sites of neoangiogenesis,
such as in microvessels invading the brain parenchyma. This
suggests that  -catenin transcriptional activity in vascular
development may be transient and expressed only when an-
giogenesis occurs.
Another possibility to explain the presence of lacunae and
irregular vascular lumen may be related to the role of  -cate-
nin in modulating endothelial cell activation by VEGF. In a
recent work (Lampugnani et al., 2003), we found that in ab-
sence of  -catenin, VEGF receptor-2 signaling to cell prolif-
eration is not inhibited by confluency. This may cause an
uncontrolled endothelial cell proliferation and an irregular
organization of the vasculature.
In conclusion, inhibition of  -catenin expression in the
endothelium leads to the death of embryos in utero due to
alterations in vascular morphogenesis. Interestingly, VE-cad-
herin gene inactivation induced a more dramatic vascular
phenotype leading to fetal death at earlier stages of develop-
ment (Carmeliet et al., 1999). Hence, VE-cadherin plays a
complex role in vascular morphogenesis, which seems to a
substantial extent independent from  -catenin interaction
and signaling.
Materials and methods
Transgenic mice and crossings
The generation of  -catenin flox and flox del mice has been described pre-
viously (Brault et al., 2001). The Tie2-Cre transgenic mice were a gift of Dr.
Yanagisawa (University of Texas Medical Center, Dallas, TX) (Schlaeger et
al., 1997; Kisanuki et al., 2001). In the mating scheme devised, only one
flox allele needs to undergo recombination to create endothelial  -catenin
 /  mice. In a first cross, homozygous Tie2-Cre transgenic mice were
mated with mice heterozygous for the  -catenin flox del allele. 50% of the
offspring inheriting both the flox del allele and a Tie2-Cre were then mated
with homozygous flox  -catenin mice to obtain embryos with the Tie2-Cre
transgene together with one flox and one flox del allele. DNA isolated from
yolk sac of embryos and tail biopsies were used for genotyping animals.
Different combinations of wild-type, flox and/or flox del  -catenin alleles
were identified by PCR using primers RM41, RM42, and RM43 as de-
scribed in Brault et al. (2001). For the identification of the Tie2-Cre gene,
F-Tie2 (5 -GAGGTGTGGCAGGCTTGAGAT-3 ) and antisense primer Cre
minus (5 -CCAGCAGGCGCACCATTGCCC-3 ) generate a 1,200-bp
product.
Antibodies
Mouse mAbs were as follows: anti- -catenin, anti- -catenin, anti-plako-
globin, anti-p120, and anti-P-tyrosine (PY20, HRP-conjugated) were from
Transduction Laboratories. Rat mAbs were from the Dejana laboratory as
follows: anti-VE-cadherin clone BV13, (Corada et al., 1999), anti-CD31/
PECAM clone MEC7.46, (Vecchi et al., 1994). The polyclonal rabbit anti-
ZO-1 was purchased from Zymed Laboratories. The polyclonal rabbit anti-
desmoplakin Ch-1 has been described previously (Valiron et al., 1996).
Embryological techniques and immunostaining
For whole-mount staining with anti-PECAM antibodies, embryos were
fixed in Dent’s fixative (methanol and DMSO, 4:1) to minimize unspecific
binding and for permeabilization, and embryos were incubated for 3 h in
PBS containing 0.1% Tween 20 and 2% BSA. The anti-PECAM primary an-
tibody was followed by an amplification step with rabbit anti–rat IgG
(DakoCytomation) and the secondary antibody rat APAAP (alcaline
phosphatase and rat anti-alcaline phosphatase; DakoCytomation) and de-
veloped with the NBC/BCIP kit from Promega.
For histological examination, fixed embryos were dehydrated, embed-
ded in paraffin, and sectioned at 5  m, according to standard procedures.
Sections were dewaxed, rehydrated, and counter-stained with Nuclear
Fast Red (Vector Laboratories). Immunostaining on PFA-fixed specimens
was performed as described previously (Lampugnani et al., 2002). Em-
bryos or cultured cells (see below) were immersion fixed in 4% freshly de-
polymerized PFA in HBSS (0.1 M Hepes, 0.15 M NaCl, 5 mM KCl, 5 mM
glucose, 1 mM CaCl2 and 1 mM MgCl2, pH 7.4) for 1 h on ice. For  -cate-
nin and desmoplakin staining, cultured cells were fixed for 5 min at  20 C
in methanol. Cells were subjected to the labeling procedure (see below),
whereas the embryos were subsequently transferred to a graded sucrose
series of 12, 15, and 18% sucrose in HBSS, embedded in Tissue Tek
®
O.C.T. (Sakura Finetek), frozen in liquid nitrogen, and stored at  80 C be-
fore cryosectioning.
Cryostat sections (8–12  m thick) were cut using a cryotome (model
CM3050S; Leica), mounted on poly-L-lysine–coated glass slides (Menzel-
Glaser), and dried. Sections were postfixed in 4% PFA/HBSS on ice and
washed in Tris-buffered saline (pH 7.6) containing 1 mM CaCl2 (TBS).
For immunostaining of embryo’s sections and for endothelial cells, un-
specific binding was minimized by incubation in 5% (wt/vol) skimmed
milk for 30 min, 0.3% (vol/vol) Triton X-100 (Serva), and 0.04% (wt/vol)T
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NaN3 in TBS. Antibodies were diluted in TBS containing 1% BSA and incu-
bated over night at 4 C. After several washes in TBS, sections and cells
were incubated with secondary antibody for 1 h at RT. To visualize cell nu-
clei, samples were washed in TBS and counterstained with nuclear dye
Hoechst 33258 (Sigma-Aldrich). Specimens were mounted in 90% glycerol
containing paraphenylenediamine as an anti-bleaching agent, and fluores-
cence was observed with an epifluorescence microscope (Leica) and digi-
tally documented with a camera, (SenSys; Roper Scientific). Images were
computer processed using Adobe Photoshop
® version 6 for Macintosh.
Conventional EM
EM specimens were fixed and embedded as described previously (Liebner et
al., 2000). For the quantification of fenestrae, the total length of the vessel
wall was measured using Carnoy software, version 2.0 for Macintosh, and the
number of fenestrations was counted at the same magnification. For the
graphical presentation, the relative incidence of fenestrae/ m was calculated.
Culture of endothelial cells and adeno-Cre infection
Endothelial cells with homozygous null mutation of the  -catenin gene
( -catenin flox del/flox del) were isolated from E9.5 embryos (Carmeliet et
al., 1999; Balconi et al., 2000). The endothelial nature of the cells was
confirmed by FACS
®, Western blot, and immunofluorescence microscopy
with antibodies to endothelial markers as described in the Results section.
Cells were routinely cultured in DME with 20% FCS (Hyclone), endo-
thelial cell growth supplement (5  g/ml, home-made from calf brain), and
heparin (100  g/ml; Sigma-Aldrich) maintenance medium (Balconi et al.,
2000) on gelatin-coated tissue culture vessels.
The adeno vector–expressing Cre recombinase was a gift of Frank Gra-
ham (McMaster University, Hamilton, Ontario, Canada) and was de-
scribed previously (Anton and Graham, 1995; Wang et al., 1995). For the
infection, 2 plaque-forming units/cell were used. To increase efficiency, a
second infection was performed after 9–12 h.
Immunoprecipitation and Western blot analysis
10
5/cm
2 cells were cultured for 4 d in maintenance medium before the ex-
periments, and scraped in lysis buffer (50 mM Tris and 150 mM NaCl, pH
7.4, containing 1% Triton X-100, 1% Nonidet P-40, 1 mM phenylmethyl-
sulfonyl fluoride, 2 mM Ca
2 , 15  g/ml leupeptin, 71  g/ml phenanthro-
lyne, and 20 U/ml aprotine [Sigma-Aldrich], 300  M vanadate, and 600
mM hydrogen peroxide). The insoluble material was removed by centrifu-
gation at 12,000 rpm for 10 min. Alternatively, cultured cells were lysated
by boiling in a modified Leamli sample buffer (2% SDS, 20% glycerol, and
125 mM Tris-HCl, pH 6.8). The protein content was measured according
to the BCA method (Pierce Chemical Co.). For immunoprecipitation exper-
iments, samples (each containing 900  g proteins) were precleared with
protein G (Amersham Biosciences) and incubated with protein G previ-
ously conjugated with the appropriate antibody. After washing, immuno-
precipitates or total cell lysates were separated by SDS-PAGE under reduc-
ing conditions and were analyzed in immunoblot with specific antibodies.
In vitro functional tests
Paracellular permeability through endothelial cell monolayers and in vitro
wounding were measured as described previously (Corada et al., 2002).
Cord formation in Matrigel™ matrix
The formation of tridimensional cord-like structures on Matrigel™ matrix
was as described previously (Taraboletti et al., 2002).
Online supplemental material
A concise description of the data presented in each supplemental figure is
introduced on citation in the text. Details on the experimental procedure
and further comments on the data reported can be found in the online
supplemental legends, available at http://www.jcb.org/cgi/content/full/
jcb.200212157/DC1.
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